Systolic Blood Pressure Intervention Trial (SPRINT)
2-arm, multicenter, randomized clinical trial
SPRINT is a research study funded by the National Institutes of Health to answer the following question:
"Will lower blood pressure reduce the risk of heart and kidney diseases, stroke, or age-related declines in memory and thinking?"
High blood pressure is a leading cause of death and disability in the US and worldwide. Over 60% of people over age 65 have high blood pressure, and the number of people with high blood pressure is increasing.
More than 9,000 participants will be enrolled into the study at over 90 clinics across the United States and in Puerto Rico. SPRINT participants will be seen regularly by experts in blood pressure management for a period of 4 to 8 years. At the end of the trial, the results of SPRINT will tell us if a lower recommended blood pressure might help to decrease stroke, heart disease, progression of chronic kidney disease, and age-related losses of memory and thinking.
Visit website: https://www.sprinttrial.org/
See also: National Institutes of Health (NIH) - Medical research agency that supports scientific studies
Systolic Blood Pressure Intervention Trial (SPRINT) News
Extend life expectancy up to 3 years by aggressively lowering BP
EurekAlert! - 26-Feb-2020
Middle-aged adults at high cardiovascular risk have this chance now based on new studyRead more...